These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 32403105)

  • 101. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 103. SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis.
    Guo Z; Cai C; Zhou K; Song L; Wang X; Chen D; Weng G; Huang S
    Sci Rep; 2024 Aug; 14(1):20150. PubMed ID: 39209911
    [TBL] [Abstract][Full Text] [Related]  

  • 104. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
    Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
    Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
    [TBL] [Abstract][Full Text] [Related]  

  • 105. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.
    Li J; Sheng C; Li W; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
    Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
    Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
    [TBL] [Abstract][Full Text] [Related]  

  • 108. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
    Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
    Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.
    Chen D; Chen W; Xu Y; Zhu M; Xiao Y; Shen Y; Zhu S; Cao C; Xu X
    J Med Genet; 2019 Jan; 56(1):43-49. PubMed ID: 29967134
    [TBL] [Abstract][Full Text] [Related]  

  • 110. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
    Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
    Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
    [TBL] [Abstract][Full Text] [Related]  

  • 111. MicroRNA‑663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4.
    Liu Y; Jiao D; Tian Z
    Mol Med Rep; 2019 Jan; 19(1):711-718. PubMed ID: 30431118
    [TBL] [Abstract][Full Text] [Related]  

  • 112. CD276 is a promising biomarker for the prognosis of clear cell renal cell carcinoma.
    Yu YH; Xu JH; Chen H; Lin YX; Ou-Yang J; Zhang ZY
    Kaohsiung J Med Sci; 2024 Oct; 40(10):926-933. PubMed ID: 39210603
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
    Gong M; Xu Y; Dong W; Guo G; Ni W; Wang Y; Wang Y; An R
    Acta Histochem; 2013 Oct; 115(8):810-5. PubMed ID: 23664661
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients.
    Zhu WK; Xu WH; Wang J; Huang YQ; Abudurexiti M; Qu YY; Zhu YP; Zhang HL; Ye DW
    J Cell Biochem; 2020 Feb; 121(2):1552-1562. PubMed ID: 31512789
    [TBL] [Abstract][Full Text] [Related]  

  • 116. ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.
    Xu T; Ruan H; Gao S; Liu J; Liu Y; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Shi J; Liang H; Yang H; Chen K; Zhang X
    Aging (Albany NY); 2020 Jan; 12(2):1808-1827. PubMed ID: 32003757
    [TBL] [Abstract][Full Text] [Related]  

  • 117. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.
    Hoffmann NE; Sheinin Y; Lohse CM; Parker AS; Leibovich BC; Jiang Z; Kwon ED
    Cancer; 2008 Apr; 112(7):1471-9. PubMed ID: 18260086
    [TBL] [Abstract][Full Text] [Related]  

  • 118. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 119. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
    Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
    Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
    [TBL] [Abstract][Full Text] [Related]  

  • 120. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
    Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.